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Summary: The aim of this study was to assess the prevalence and
the molecular epidemiology of human T-lymphotropic virus type 1
(HTLV-1) in a group of pregnant women living in Guinea Bissau. We
studied 427 consecutive pregnant women attending 10 centers for
HIV-1 infection monitoring in Bissau. HTLV-1 infection was found in
2.6% of the patients. Phylogenetic analysis of the long terminal repeat
region showed that 10 isolates were of the cosmopolitan subtype
(HTLV-1a) and that only 1 was of the widespread Central African
subtype (HTLV-1b). All the cosmopolitan isolates belonged to the
HTLV-1aD subgroup, which was first described in North Africa and
clustered with other Senegal and Guinea isolates to form a significant
West African clade. Our data show a high prevalence of HTLV-1 in
Guinea Bissau and suggest the existence of a trans-Saharan strain
distributed in North and West Africa, which probably crossed the
desert in the past as a result of contacts between nomadic and sed-
entary populations or along trading routes.
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Unlike other retroviruses, human T-lymphotropic virus type1 (HTLV-1) is genetically conserved and has a slow
evolutionary rate that has recently been estimated as being
between 1027 and 1026 substitutions per site per year for env
and long terminal repeat (LTR).1 Phylogenetic analyses of
viral genes have shown the existence of 6 HTLV-1 subtypes
(a to f) characterized by a mean sequence divergence of,10%
and a different geographic distribution. Five of these can be
detected in African populations2: subtype 1b is the most
widespread subtype in Central Africa; subtypes 1d, 1e, and 1f
have been isolated in pygmies living in the same region;3–5 and
the 1a (cosmopolitan) subtype is found all over the world.
Analysis of the LTR of subtype 1a allows the recognition
of 5 divergent subgroups: HTLV-1aA (transcontinental) is
found at different prevalence rates throughout the world and
has been identified in South Africa, 1aB is reported in Japan
and in subjects of Japanese descent in the Americas, 1aC has
been reported in Coˆte d’Ivoire and Ghana as well as in people
living in Central and South America, 1aD was first isolated in
North Africa,4,6 and 1aE has been reported in subjects of
African descent living in Peru.7
HTLV-1 is widespread in sub-Saharan Africa, particu-
larly in West and Central Africa. In West Africa, the reported
rates of seropositivity for anti-HTLV-1 antibodies vary from
1% to more than 5% among blood donors and/or pregnant
women in Ghana,8 Benin,9 Burkina Faso,10 Mali,11 Senegal,12
Nigeria,13 and Guinea Bissau.14
The prevalence of HTLV-1 infection in Guinea Bissau
is one of the highest in Africa. A serosurvey carried out in
the year 2000 found that 9.3% of blood donors and 3.6% of
the general population of Bissau were antibody-positive,15
whereas the prevalence in pregnant women was 3.3% in
1992.16 Little is still known about the distribution of HTLV-1
subtypes/subgroups in the country.
The aim of this study was to assess the prevalence of
HTLV-1 infection in a consecutive series of pregnant women
attending a counseling and assistance program for the pre-
vention of the vertical transmission of HIV infection and to
investigate its molecular epidemiology in this highly infected
area.
MATERIAL AND METHODS
Patients
A total of 427 blood samples were obtained from
a consecutive series of pregnant women of different ethnic
groups from Bissau and the surrounding region who were
attending 10 centers for the prevention of mother-to-child
transmission of HIV in the town of Bissau. Their mean age was
23.2 years (SD = 5.2). All the main ethnic groups of Bissau
were represented in our case file (19% Fula, 13% Mandinga,
12% Papel, 18.8% Balanta, and ,10% others). Guidelines of
the Guinea-Bissau Ministry of Health were observed, and
informed consent forms were obtained.
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Methods
Approximately 100 mL of whole blood was spotted onto
filter papers (Guthrie cards), which were allowed to dry
overnight at room temperature before being frozen at 230C
until use.
Eluates from the filter papers were screened for HTLV
antibodies using an enzyme-linked immunosorbent assay
(ELISA; Murex HTLV I+II; Murex Biotech Limited, Dartford,
United Kingdom). Whole genomic DNAwas purified from the
dried blood using a commercial kit (Generation Capture Card
Kit; Gentra Systems, Minneapolis, MN) and tested for HTLV
DNA by amplifying LTR and tax regions using different
polymerase chain reaction (PCR) protocols.
The nested PCR protocols used for LTR (nt 4 to 697)
and tax (nt 7358 to 7516) amplification have been described
elsewhere.17
The LTR PCR fragments were purified using spin
columns (QIAquick PCR Purification Kit; Qiagen, Hilden,
Germany) and directly sequenced in both directions in an
automated sequencing apparatus (ABI Prism 3100 Genetic
Analyser; Applied Biosystems, Foster City, CA) using forward
and reverse inner primers and the dideoxy chain termination
method (BigDye Terminator Cycle Sequencing Reaction
Mixture; Perkin-Elmer, Foster City, CA).
The sequences were submitted to the GenBank with
assigned accession numbers (EU401868–EU401878).
Phylogenetic Analysis
Phylogenetic analyses were made of LTR sequences
(630 nucleotides in length). Three LTR sequences (GB2722,
GB3484, and GB2304) were shorter than the others (375 base
pairs [bp] for GB2722 and 608 bp for GB3484 and GB2304)
and were analyzed separately.
The patients’ isolates were aligned with reference
sequences retrieved from the Genbank using CLUSTALW.18
The best-fitting substitution models and parameters were
estimated using a hierarchical likelihood ratio test imple-
mented using the MODELTEST 3.06 computer program.19
The selected model was that of Tamura and Nei20 with discrete
g-distributed rates among sites (a shape = 0.5). Phylogeny was
reconstructed using the neighbor joining (NJ) clustering
method and maximum likelihood (ML) analysis. Only the
topologies confirmed by the 2 methods were considered sig-
nificant. The phylogenetic reconstruction, trees, and genetic
distance statistics were obtained using MEGA version 3.121
and PAUP* version 4.0b10 (D. Swofford, Sinauer Associates,
Inc., Sunderland, MA).
The significance of the interior branches in the NJ tree
was tested by means of bootstrap analysis with 1000
replicates; bootstrap values of $60% were considered
significant. Branch length significance was estimated using
the likelihood ratio test for a branch length of 0, implemented
in PAUP* (P # 0.05 significance).
Strains Used for the Phylogenetic Analyses
The names and accession numbers of the reference
strains used for LTR phylogenetic analysis were as follows:
CH26 (D23690), GB233 (D23692), AINU(D23694), pGH78
(D23693), ATK1 (J02029), RKI4 (AF054627), RKl5
(AY854249), Qu1 (Y16475), Qu2 (Y16476), Qu3
(Y16477), Me1 (Y16478), Me2 (Y16479), Me3 (Y16480),
Nar (AF063820), Bl1 (Y16481), B12 (Y16482), Bl3
(Y16483), Ni1 (Y16484), Ni2 (Y16487), HS35 (D13784),
MT2 (L03562), Boi (L36905), TBH2 (L76025), TBH5
(L76027), H23 (L76312), StDen (L76306), GAB7
(L76311), PH236 (L76307), T49 (L76305), 12503 (L76309),
H24 (L76308), ELzaire (S74562), mel5 (L02534), BO
(U12804), OD (U12805), Pr52 (U12806), Pr144 (U12807),
JCP (X88875), efe1 (Y17014), Lib2 (Y17017), MOMJ
(Z31659), MT4 (Z31661), MWMG (Z31662), ITIS (Z32527),
FrGu1 (AY324785), PH906 (AY342303), PH 907 (AY342304),
6Aissa (AY342300), 2BAbdou (AY342302), 5BMarieto
(AY342301), PH908 (AY342305), PH979 (AY342306),
BD89517 (DQ235699), and NM1626 (AF063821).
Statistical Analysis
Significances were tested using the Student t test for
comparisons of mean values and the Pearson x2 test for com-
parisons of proportions. All the analyses were made using
the SPSS package (SPSS version 11; SPSS Inc., Chicago, IL).
RESULTS
Eleven (2.6%) of the 427 samples analyzed were
reactive to the anti-HTLV-1/2 ELISA, and all of them had
positive results to tax and LTR PCR amplification. The
characteristics of the 11 HTLV-1–positive subjects are shown
in Table 1.
Analysis of the LTR sequences in the 11 isolates with
54 reference sequences representing all the known HTLV-1
subtypes and subgroups showed 6 significant clades corre-
sponding to the known HTLV-1 subtypes (HTLV-1a, HTLV-1b,
HTLV-1c, HTLV-1d, HTLV-1e, and HTLV-1f). Ten patient
isolates (including the shorter GB2722, GB3484, and
GB2304) belonged to the cosmopolitan subtype (HTLV-1a);
the other isolate (obtained from a Fula patient) was included
within the Central African subtype HTLV-1b (Fig. 1). The
cosmopolitan subtype segregated into 5 significant mono-
phyletic groups corresponding to the known subgroups A to E:
TABLE 1. Demographic and Virologic Characteristics of the
Women From Whom the 11 Typed HTLV-1 Isolates
Were Obtained
Isolate Age (y) Ethnic Group HIV-1
GB2304 18 Mandinga N
GB2383 18 Papel N
GB2412 29 Fula N
GB2524 30 Mancanha N
GB2604 21 Mandinga P
GB2722 32 Mansonca N
GB3474 26 Fula N
GB3484 35 Fula N
GB4772 20 Balanta N
GB10533 16 Mixed P
GB12313 21 Felupe N
N indicates negative; P, positive.
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FIGURE 1. NJ tree of a 630-bp fragment of the HTLV-1 LTR region. The tree was rooted using Melanesian strain HTLV-1c (Mel5)
as the outgroup, and the numbers on the branches give the bootstrap percentage values using 1000 replicates (bootstrap
values $60%); the asterisks indicate that the branch length was statistically significant on ML testing (*0.001 , P # 0.05; **P #
0.001). Lower case characters indicate the strains grouping in different subtypes, and upper case characters indicate the strains
grouping in different HTLV-1a subgroups. The 2 clades of HTLV-1aD have been highlighted. N indicates North African clade; W,
West African clade. The isolates described in the text are shaded. Shorter sequences (GB2722, GB3484, and GB2304) were not
included in this analysis.
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all 10 cosmopolitan isolates were in subgroup 1aD (corre-
sponding to the North African clade). In particular, they
formed a significant cluster with another 7 isolates from
Guinea Bissau and Senegal retrieved from databases. The
HTLV-1aD subgroup included 2 significant clades: one en-
compassing most isolates from Mauritania, Morocco, and
Algeria, supported by an NJ bootstrap value of 84.4% (P #
0.001 at ML analysis) and the other including strains from
Senegal and Guinea Bissau, with a bootstrap value of 91.2%
(P # 0.001; see Fig. 1). One strain from Morocco (Pr144)
formed an outgroup of the Senegal/Guinean clade. The mean
genetic distance between the 2 clades (North and West
African) within HTLV-1aD was 1.2% compared with a mean
of 2.0% from HTLV-1aB and 2.5% from HTLV-1aC.
Analysis of the nucleotides of the HTLV-1aD LTR
sequences showed that the isolates from Senegal and Guinea
Bissau differed from the North African strains in terms of
3 mutations at nucleotides C367A, A547C, and T615C.
Analysis of the 3 shorter sequences showed that they were
all included in the Senegal/Guinean clade and confirmed the
presence of the 3 mutations.
Supplementary Epidemiologic Data
HIV-1 infection was significantly more frequent among
the HTLV-1–positive women than among the HTLV-1–
negative women (2 [18.2%] of 11 women vs. 20 [4.8%] of
416 women; P = 0.04 by x2 test).
There was no significant difference in the distribution of
the ethnic groups among the HTLV-1–positive or –negative
subjects, although an excessive number of Fula and Mandinga
subjects were observed among the former (see Table 1).
DISCUSSION
Africa represents the cradle of primate T-lymphotropic
viruses2 and hosts most HTLV-1 subtypes and subgroups. Our
data show that the cosmopolitan subtype of HTLV-1 (HTLV-
1a) is prevalent in Guinea Bissau, because only 1 of our 11
isolates was not cosmopolitan but belonged to the most
prevalent subtype in Central Africa (HTLV-1b).
Guinea Bissau occupies an area of approximately
36,000 km2 and has a population of 1.6 million people char-
acterized by a high degree of cultural and genetic heteroge-
neity. There are a number of ethnic groups with different
languages, religions, and cultures, many of which are also
living in bordering countries. In particular, the Fula are a
formerly seminomadic population of approximately 30 million
individuals now dispersed throughout the Sahel region
(Nigeria, Guinea Conakry, Chad, and Cameroon).22 Interest-
ingly, this was the most frequently represented ethnic group
among the HTLV-1–infected subjects, and the only isolate
belonging to the Central African subtype came from a Fula
subject.
The presence of HTLV-1 has been reported in various
Sahara countries, particularly Morocco,23 Tunisia,24 Egypt,25
Mali,11 Mauritania, and Algeria, and LTR analyses of some of
these isolates have identified the North African subgroup of
the cosmopolitan subtype (HTLV-1aD).6
The phylogenetic analyses of all the cosmopolitan
isolates from our patients, together with other previously
described isolates from Guinea Bissau and Senegal,12,26
showed that they belonged to the HTLV-1aD subgroup. In
comparison with the North African isolates, the sub-Saharan
sequences clustered together, and 2 significant clades (one
including all but 1 North African isolate and the other
including all the Senegal/Guinean isolates) were observed in
the HTLV-1aD subgroup. The mean divergence between
northern and western isolates was 1.2% in LTR, which is less
than the reported divergence among HTLV-1 subtypes and
based on 3 polymorphic sites. Given the low evolutionary
rate of the virus,1 it can be postulated that the segregation of
the northern and western clades took a long time to produce
such a degree of divergence.
Taken together, these observations support the existence
of a trans-Saharan HTLV-1 strain that includes 2 clades: one
from North Africa and the other from West Africa. Significant
contacts between Berber tribes and West African sub-Saharan
populations have been documented since ancient times.27 The
mixture of cultures increased around the 11th century, when
the southern populations were progressively converted to
Islam and empires, such as the Ghana and Mali empires at
the southern terminus of the caravan routes, successively
expanded and disappeared.22 The trans-Saharan routes were
extensively used for the slave trade from south to north,28 and
sea routes also contributed to the slave trade to Morocco and
Mediterranean North Africa. These multiple complex relations
may explain the existence of a trans-Saharan HTLV-1 sub-
group, although its geographic origin remains an enigma.
The existence of a western clade in the HTLV-1aD subgroup
that was separate from a northern clade may have been at-
tributable to different phenomena. It is possible to hypothesize
the past arrival in West Africa of a strain of HTLV-1aD coming
from North Africa. Nevertheless, the high prevalence of
HTLV-1aD in Guinea Bissau seems to support the hypothesis
that this area was the source of the variant, because this
subgroup is clearly the main contributor to the country’s dis-
proportionate prevalence of HTLV-1 infection. For this rea-
son, a second hypothesis may be that the western clade was
attributable to the rapid expansion of 1 viral strain as the
result of a recent increase in population risk and/or changes
in the main route of transmission. Larsen et al15 found
a 3.6% prevalence of HTLV-1 infection among adults living
in Guinea Bissau, particularly among HIV-positive women
and, in agreement with other authors,14 concluded that sexual
transmission played a central role in spreading the infection in
the country, probably amplified by various parenteral risk
factors as has been postulated in the case of other retroviruses
such as HIV-2.29 Our data show a prevalence of 2.6% among
pregnant women and a frequency of HIV-1 infection signifi-
cantly higher among those who were HTLV-1–positive.
In conclusion, our data, confirming the high spread of
HTLV-1 infection in Guinea Bissau, show that HTLV-1aD is
the prevalent subgroup in this country and in Senegal,
extending the area of the distribution of this strain from North
to West Africa. They also suggest the existence of a trans-
Saharan HTLV-1aD, which probably crossed the desert
sometime in the past through nomadic populations or along
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trade routes. Further studies are needed to clarify the origin
and the epidemiologic history of such an interesting viral
strain.
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